15 reports

Global Addiction Disorder Epidemiology and Patient Flow Analysis - 2017 ##.

  • Addiction Disorder
  • Mental Health
  • United States
  • World
  • Forecast

Global Addiction Disorders Epidemiology and Patient Flow Analysis - 2016 ##.

  • Addiction Disorder
  • Mental Health
  • United States
  • World
  • Forecast

Europe Addiction Disorder Epidemiology and Patient Flow Analysis - 2017 ##.

  • Addiction Disorder
  • Europe
  • France
  • Germany
  • Forecast

Specialty treatment services provide treatment relating to eating disorders and addiction.

  • Addiction Disorder
  • Specialty Hospital
  • World
  • Acadia Healthcare Company, Inc.
  • Universal Health Services, Inc.
  • Target
  • Clinical Trial profile. 79 Trial Title

Alcohol Addiction Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Alcohol Addiction Global Clinical Trials Review, H1, 2017" provides an overview of Alcohol Addiction clinical trials scenario. This report provides top line data relating to the clinical trials on Alcohol Addiction....

  • Addiction Disorder
  • Antiseptics
  • United States
  • World
  • Alkermes plc
  • Clinical Trial profile. 71 Trial Title
  • Target

Alcohol Addiction Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Alcohol Addiction Global Clinical Trials Review, H2, 2016" provides an overview of Alcohol Addiction clinical trials scenario. This report provides top line data relating to the clinical trials on Alcohol Addiction. Report...

  • Addiction Disorder
  • Antiseptics
  • Neurology
  • Therapy
  • World

" Opioid addiction is one of the worst public health crises in our nation' s history.

  • Addiction Disorder
  • Opioid
  • United States
  • Product Initiative
  • Addex Therapeutics Ltd
  • Clinical Trial profile. 318 Trial Title
  • Target

Risperidone for Bipolar Disorder with Comorbid Substance Use Disorder Divalproex ER vs.

  • Addiction Disorder
  • Clinical Trial
  • Pharmaceutical
  • United States
  • World

Company believe that PDE## inhibitors could be effective therapeutics for the treatment of addiction and compulsive disorders as well as movement disorders.

  • Addiction Disorder
  • Antiseptics
  • United States
  • Product Initiative
  • MediciNova, Inc.

The company develops medications to treat addiction and related disorders.

  • Addiction Disorder
  • Antiseptics
  • United States
  • Product Initiative
  • MediciNova, Inc.
  • Nicotine Addiction - Pipeline by CV Sciences Inc, H1 2018
  • Small Molecules to Inhibit Dopamine, Serotonin, Norepinephrine Transporters for Central Nervous System Disorders - Drug Profile

The drug candidate selectively blocks the orexin-## receptor resulting in the blockage of addiction.

  • Addiction Disorder
  • Psychotic Disorder
  • United States
  • Product Initiative
  • Addex Therapeutics Ltd
  • NICOTINE ADDICTION - PIPELINE BY CV SCIENCES INC

The company develops medications to treat addiction and related disorders.

  • Addiction Disorder
  • Opioid
  • United States
  • Product Initiative
  • Omeros Corporation
  • AUG 01, 2017: AMYGDALA NEUROSCIENCES INITIATES PHASE 1B CLINICAL STUDY OF ANS-6637, THE FIRST-IN-CLASS SELECTIVE ALDH2 INHIBITOR IN DEVELOPMENT AS A TREATMENT FOR SUBSTANCE USE DISORDER
  • OCT 18, 2017: ALTASCIENCES CONDUCTS ALCOHOL DRUG-DRUG INTERACTION STUDY FOR AMYGDALA NEUROSCIENCES

Drug Addiction - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2018, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape. Drug addiction, also called...

  • Addiction Disorder
  • Therapy
  • United States
  • Company
  • Product Initiative

Drug Addiction - Overview Drug Addiction - Therapeutics Development NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR DRUG ADDICTION, H## 2017 PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR DRUG ADDICTION, H## 2017 Filing rejected/ Withdrawn ## ## Phas

  • Addiction Disorder
  • Opioid
  • Therapy
  • United States
  • Product Initiative
  • ASP-2905 - DRUG PROFILE

Addiction - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Addiction - Pipeline Review, H2 2015’, provides an overview of the Addiction’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Addiction, complete with comparative analysis at various stages,...

  • Addiction Disorder
  • Opioid
  • Research And Development
  • United States
  • Company Operations